Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development.
第一作者:
Erich,Koller
第一单位:
Department of Functional Genomics, Isis Pharmaceuticals, Carlsbad, California 92008, USA. ekoller@isisph.com
作者:
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);乳腺肿瘤(Breast Neoplasms);细胞生长过程(Cell Growth Processes);细胞系, 肿瘤(Cell Line, Tumor);DNA, 肿瘤(DNA, Neoplasm);基因文库(Gene Library);神经胶质瘤(Glioma);人类(Humans);小鼠(Mice);小鼠, 裸(Mice, Nude);寡核苷酸类, 反义(Oligonucleotides, Antisense);RNA, 信使(RNA, Messenger);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1158/0008-5472.CAN-05-1531
PMID
16489005
发布时间
2021-12-03
- 浏览23

Cancer research
2059-66页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文